Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Artiva Biotherapeutics In...

    NASDAQ: ARTV · Real-Time Price · USD
    2.79
    -0.31 (-10.00%)
    At close: Aug 19, 2025, 3:59 PM
    2.78
    -0.36%
    After-hours: Aug 19, 2025, 07:31 PM EDT

    Artiva Biotherapeutics Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Revenue
    		 n/a n/a 251K 2.6M 29.26M 29.26M 30M 27.64M 989K 989K
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a 251K 2.6M 29.26M 29.26M 30M 27.64M 989K 989K
    Operating Income
    		 -81.58M -74.96M -67.28M -60.99M -31.84M -27.48M -30.67M -18.7M -29.51M -17.69M
    Interest Income
    		 7.45M 5.89M 4.67M 3.08M 1.65M 1.65M 2.02M 1.44M 1.02M 1.02M
    Pretax Income
    		 -68.25M -61.53M -55.19M -56.87M -28.12M -29.45M -32.2M -21.3M -32.58M -16.72M
    Net Income
    		 -68.25M -61.53M -55.19M -56.95M -28.2M -29.52M -32.27M -21.3M -32.58M -16.72M
    Selling & General & Admin
    		 19.83M 18.74M 17.2M 15.42M 13.39M 13.59M 13.91M 10.74M 7.96M 3.91M
    Research & Development
    		 61.75M 56.23M 50.33M 48.17M 47.71M 46.64M 50.25M 39.1M 26.03M 14.77M
    Other Expenses
    		 n/a n/a 147K 147K 147K 116K -84K -84K -84K -53K
    Operating Expenses
    		 81.58M 74.96M 67.53M 63.59M 61.1M 60.23M 64.16M 49.84M 34M 18.68M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 58.77M 74.96M 67.53M 63.59M 61.1M 60.23M 64.16M 49.84M 34M 18.68M
    Income Tax Expense
    		 n/a n/a n/a 72K 72K 72K 72K n/a n/a n/a
    Shares Outstanding (Basic)
    		 24.38M 24.34M 11.26M 18.9M 23.28M 17.58M 20.43M 9.36M 17.58M 17.58M
    Shares Outstanding (Diluted)
    		 24.38M 24.34M 11.26M 18.9M 23.28M 17.58M 20.43M 9.36M 17.58M 17.58M
    EPS (Basic)
    		 -3.44 -3.19 -3.15 -2.87 -0.75 -1.03 -1.19 -0.65 -1.85 -0.95
    EPS (Diluted)
    		 -3.44 -3.19 -3.15 -2.87 -0.75 -1.03 -1.19 -0.65 -1.85 -0.95
    EBITDA
    		 -79.71M -72.49M -64.85M -58.58M -29.5M -28.7M -31.9M -20.53M -31.89M -17.11M
    EBIT
    		 -58.77M -74.96M -67.28M -60.99M -31.84M -30.97M -34.17M -22.2M -33.01M -17.69M
    Depreciation & Amortization
    		 1.87M 2.47M 2.43M 2.41M 2.34M 2.27M 2.27M 1.67M 1.12M 578K

    Add to Watchlist